Google introduces Gemini 3.1 Flash-Lite in preview via AI Studio and Vertex AI, promising faster responses and lower costs for high-volume apps.

Error logs and GitHub pull requests hint at GPT-5.4 quietly rolling out in Codex, signaling faster iteration cycles and continuous AI model deployment.

“Testing and control sit at the center of how complex hardware is developed and deployed, but the tools supporting that work haven’t kept pace with system complexity,” said Revel founder and CEO Scott ...

A Hybrid Machine Learning Framework for Early Diabetes Prediction in Sierra Leone Using Feature Selection and Soft-Voting Ensemble ...

Speechify's Voice AI Research Lab Launches SIMBA 3.0 Voice Model to Power Next Generation of Voice AI SIMBA 3.0 represents a major step forward in production voice AI. It is built voice-first for ...

For over a decade, confusion over the size of the proton has held scientists back. Disagreeing measurements of the subatomic particle’s radius meant that scientists couldn’t test one of their key ...

Florida state Rep. Adam Anderson championed the Sunshine Genetics Act, the first state-backed genetic disease screening program in the nation. Anderson's son, Drew, died in 2019 from Tay-Sachs disease ...

The last time we did comparative tests of AI models from OpenAI and Google at Ars was in late 2023, when Google’s offering was still called Bard. In the roughly two years since, a lot has happened in ...

An AI model that learns without human input—by posing interesting queries for itself—might point the way to superintelligence. Save this story Save this story Even the smartest artificial intelligence ...

WASHINGTON — A new report from the National Academies of Sciences, Engineering, and Medicine examines how the U.S. Department of Energy could use foundation models for scientific research, and finds ...

The FDA has granted Cleveland Diagnostics’ IsoPSA test premarket approval (PMA) to help detect prostate cancer in men aged 50 years or older with elevated PSA levels. IsoPSA is a blood assay that ...

CLEVELAND--(BUSINESS WIRE)--Cleveland Diagnostics, Inc., a pioneering, commercial-stage precision oncology company, announced today that the U.S. Food and Drug Administration (FDA) has approved the ...